Relay Therapeutics, Inc.RLAYNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank43
3Y CAGR-4.9%
5Y CAGR+8.0%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-4.9%/yr
vs +65.2%/yr prior
5Y CAGR
+8.0%/yr
Recent deceleration
Acceleration
-70.1pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$56.71M-26.0%
2024$76.59M+2.2%
2023$74.95M+13.6%
2022$65.98M+15.0%
2021$57.39M+48.7%
2020$38.59M+180.8%
2019$13.74M+55.2%
2018$8.86M-